UnitedHealth Group (NYSE: UNH), a number one supplier of medical insurance and healthcare companies, is anticipated to report fourth-quarter earnings subsequent week. The corporate, a market chief within the nation’s colossal healthcare trade, delivered a combined efficiency in 2024 amid headwinds like Medicare charge cuts and rising healthcare prices.
The diversified firm has a powerful observe file of dividend funds, nearly doubling the payout up to now 5 years. That makes it a pretty funding for revenue traders. Growing profitability and the administration’s optimistic earnings outlook for the 12 months recommend extra dividend hikes. In 2024, UnitedHealth’s inventory grew steadily and set a brand new file, however suffered a pointy fall and reversed most of these beneficial properties after the tragic assassination of UnitedHealthcare CEO Brian Thompson in early December. Nonetheless, it’s regaining momentum forward of the earnings.
The corporate will publish its fourth-quarter report on Thursday, January 16, at 5:55 am ET. On common, analysts following UnitedHealth predict adjusted revenue of $6.75 per share for the quarter, in comparison with $6.16 per share in This fall 2023. It’s estimated that complete revenues rose 7.8% year-over-year to $101.78 billion within the remaining three months of fiscal 2024.
Outlook
Within the September quarter report, the administration mentioned it expects full-year 2024 earnings to be within the vary of $27.50 per share to 27.75 per share, adjusted for one-off gadgets. On the midpoint, the estimate is increased than the revenue the corporate earned in 2023. Unadjusted revenue is anticipated to be between $15.50 per share and 15.75 per share in FY24.
The enterprise has confronted stress from rising healthcare prices, resulting in elevated declare payouts to clients. The brand new regulation permitting the federal government to straight negotiate drug costs with pharmaceutical corporations to scale back drug prices for Medicare beneficiaries is including to the pressure on revenues. Whereas UnitedHealth has robust fundamentals and a wholesome steadiness sheet, it has a comparatively excessive debt. The excellent news is that the corporate’s money flows have been fairly robust.
From UnitedHealth’s Q3 2024 earnings name:
“For over 20 years, there was a bipartisan consensus amongst healthcare consultants and policymakers that value-based care that’s built-in, patient-centered, and outcome-focused care is superior to the usually fragmented and unnecessarily costly fee-for-service system. Throughout 4 presidential administrations, CMS has known as for private-public innovation within the growth of value-based care fashions in Medicare and Medicaid. It gives higher outcomes for sufferers. It saves cash for the shoppers and taxpayers who fund care.“
Key Metrics
Within the third quarter, revenues grew by 9% to about $100 billion and barely exceeded Wall Road’s expectations, persevering with the latest development. All 4 enterprise segments delivered progress, translating right into a 9% rise in adjusted earnings to $7.15 per share. Apparently, quarterly earnings beat estimates constantly for over a decade. Web revenue attributable to the corporate, together with particular gadgets, elevated to $6 billion or $6.51 per share in Q3 from $5.8 billion or $6.24 per share within the prior-year quarter.
After dropping about 7% up to now 30 days, UnitedHealth’s inventory traded increased on Wednesday afternoon. The inventory’s present worth nearly matches its worth round three years in the past.